Normix (Rifaximin)

Rifaximin, the active ingredient in Normix, is a Rifamycin antibiotic presented as a 200 mg tablet for oral use. It treats travelers’ diarrhea, hepatic encephalopathy, and irritable bowel syndrome with diarrhea, primarily in adult patients requiring gastrointestinal‑selective antibacterial therapy. Its poor systemic absorption limits exposure to extra‑intestinal tissues, focusing activity within the gastrointestinal tract.

GNH USA supplies Normix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Rifaximin is a gastrointestinal‑selective antibacterial used to manage several conditions affecting the intestinal tract.

Travelers' diarrhea: Reduces the duration and severity of acute bacterial diarrhea in adult travelers. Hepatic encephalopathy: Lowers ammonia‑producing gut bacteria to help prevent recurrence of hepatic encephalopathy episodes. Irritable bowel syndrome with diarrhea (IBS‑D): Improves stool consistency and reduces abdominal discomfort in IBS‑D patients.

Rifaximin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset or queasiness. - Flatulence: increased intestinal gas. - Headache: transient mild headache. - Abdominal pain: occasional cramping.

Serious or Rare Side Effects: - Clostridioides difficile infection: rare but severe colitis. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Hepatotoxicity: elevated liver enzymes in rare cases.

Before prescribing rifaximin, clinicians should consider several precautionary measures.

- Indication verification: ensure the condition matches an approved use. - Liver function: assess hepatic status, especially in hepatic encephalopathy patients. - Renal impairment: adjust use cautiously in severe renal dysfunction. - Concomitant antibiotics: avoid simultaneous use with broad‑spectrum agents that may alter gut flora. - Pregnancy and lactation: use only if potential benefit outweighs unknown risk. - Store at ambient temperature: keep tablets below 25 °C in the original container, protected from moisture.

Rifaximin may interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase INR, monitor coagulation. - Cyclosporine: increased blood levels, monitor renal function.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in effectiveness, advise backup method. - Macrolide antibiotics (e.g., erythromycin): may increase rifaximin concentrations. - Bile acid sequestrants (e.g., cholestyramine): may reduce rifaximin absorption.